We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Venus Medtech Gains Mitral, Tricuspid Valve Pipeline in $300 Million Purchase of Cardiovalve
Venus Medtech Gains Mitral, Tricuspid Valve Pipeline in $300 Million Purchase of Cardiovalve
Venus Medtech (Hangzhou) has expanded its reach into transcatheter mitral and tricuspid valve treatments with the purchase of Cardiovalve, an Israel-based devicemaker that specializes in such products.